HOME Research Insight Key Players in the Bioprocess Containers Market Focus on New Product Launches and Expansions



Key Players in the Bioprocess Containers Market Focus on New Product Launches and Expansions


The global bioprocess containers market is expected to reach USD 1,914.6 Million by 2023 from USD 1,030.0 Million in 2018, at a CAGR of 13.2%. Growth in the bioprocess containers market can be attributed to the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.

The bioprocess containers market is consolidated in nature due to the presence of a few players. The key players in the bioprocess containers market are Thermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).

The key strategies followed by most companies in the bioprocess containers market are product launches and expansions. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018.

Thermo Fisher Scientific

Thermo Fisher Scientific held the leading position in the bioprocess containers market with a share of 24.7% in 2016. The company operates in the US, non-US developed countries, and emerging countries. Thermo Fisher offers a wide array of bioprocess container bags. The company adopted organic growth strategies in order to increase its dominance in this market. For instance, in June 2015, Thermo Fisher Scientific launched the HyPerforma single-use mixer. The product offers features such as advanced clean-in-place sterilization, optimized tubing management, rapid set-up and turnaround times, and streamlined handling of hazardous materials.

Sartorius

Sartorius held the second position in the bioprocess containers market in 2016. The company operates through two distinct segments, namely, Bioprocess Solutions and Lab Products & Services. The company offers bioprocess containers and bags through its Bioprocess Solution segment. The company adopted product launches as a key strategy for its growth. For instance, in September 2016, the company launched single-use sartocon loop assemblies with integrated polyethersulfone (PESU) membrane. These assemblies facilitate rapid and safe ultrafiltration of biologics and vaccines.

Merck KGaA

Merck ranked third in the bioprocess containers market in 2016. The company focuses on the untapped markets in Asia and makes ample investments in countries like China, India, and South Korea. For instance,

  • In February 2018, Merck KGaA invested in the production of Mobius single-use manufacturing in Wuxi, China to meet the increasing demand for biologics and other therapeutic proteins.
  • In February 2018, Merck KGaA plans to invest in the Asian region to build a robust manufacturing and distribution platform over a span of two years. This investment is for establishing new biopharmaceutical manufacturing and distribution centers in South Korea and India, with the growing demand for biopharmaceutical products.

Related Reports:

Bioprocess Containers Market by Type (2D Bags, 3D Bags, Tank Liners), Application (Process Development, Upstream, and Downstream), End Users (Biopharmaceutical, and Life Science Companies), and Region - Global Forecast to 2023

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports